Thanks, FDA: NephroGenex Investors Rejoice After New Clearance By: Benzinga via Benzinga December 14, 2015 at 12:52 PM EST NephroGenex Inc (NASDAQ: NRX), the pharma company focused on the development of therapeutics to treat kidney disease, is soaring by ... Read More >>